The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHipgnosis Song. Share News (SONG)

Share Price Information for Hipgnosis Song. (SONG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 102.00
Bid: 102.00
Ask: 102.20
Change: 0.00 (0.00%)
Spread: 0.20 (0.196%)
Open: 102.00
High: 102.20
Low: 101.80
Prev. Close: 102.00
SONG Live PriceLast checked at -
Hipgnosis Songs is an Investment Trust

To provide shareholders with an attractive and growing level of income, together with the potential for capital growth, from investment in songs and associated musical intellectual property rights.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Hipgnosis Songs Fund asset value falls on independent review

Mon, 04th Mar 2024 09:52

(Sharecast News) - Hipgnosis Songs Fund updated the market on ongoing strategic review on Monday, reporting a notable reduction in the company's fair value after a detailed report from Shot Tower Capital.

At its interim results for the six months ended 30 September, Hipgnosis said a preliminary valuation report prepared by Shot Tower Capital had indicated disparities between market data and the fair value of the company's assets.

The FTSE 250 company said at the time that, in seeking clarity on the matter, it consulted the investment advisor Hipgnosis Song Management, majority-owned by Blackstone-managed funds.

It said that, initially hesitant to offer an opinion, the advisor eventually provided a cautious assessment, and as a result, the board had advised investors to exercise prudence in relying on fair value and operative net asset value.

To independently evaluate the company's assets, the board appointed Shot Tower as lead advisor, which scrutinised Hipgnosis' portfolio, conducting a thorough bottom-up valuation analysis of each catalogue based on various factors such as copyright interests, revenue streams, vintage stability, and control rights.

The company said the preliminary valuation report provided by Shot Tower as of 1 March estimated the fair market value of the company's portfolio to be within the range of $1.8bn to $2.06bn.

Adjusting for contingent catalogue bonuses, the valuation stood between $1.74bn and $2bn.

Compared to the previous fair value as of 30 September 2023, the Shot Tower valuation reflected a notable reduction.

Additionally, Shot Tower reported the firm's cash net revenue for the 12 months ended 30 June to be $121.7m, consistent with BDO's analysis for the period ended 30 September.

Based on the Shot Tower valuation, the company said its operative net asset value declined to about $1.17 per share, significantly lower than the last reported operative net asset value of $1.7392 per ordinary share.

Translating to sterling, that equated to around 92.08p per share.

The pro-forma operative net asset value per share excluded potential corporation tax charges on asset disposal.

As a result, in light of the decreased operative net asset value, the board said it planned to reduce gearing and use free cash flow to retire debt, suspending dividends for the foreseeable future.

Shot Tower planned to present its final due diligence findings to the board by 25 March, after which the firm's directors aimed to provide a comprehensive update on Shot Tower's due diligence by 29 March.

"The newly constituted board is making good progress with the due diligence work that will underpin its strategic review," said chairman Robert Naylor.

"We are disclosing the valuation at this time given its material difference to valuations previously disclosed.

"The board will provide further detail on this when the due diligence is complete.

"The board remains focused on identifying all options to deliver shareholder value."

At 0928 GMT, shares in Hipgnosis Songs Fund were down 10.24% at 56.64p.

Reporting by Josh White for Sharecast.com.

More News
18 Apr 2024 07:41

Hipgnosis faces $1.4bn takeover by Concord Chorus

(Sharecast News) - Shares in troubled Hipgnosis Songs Fund rocketed by a third on Thursday after the music rights investor said it had agreed a $1.4bn takeover by US-based Concord Chorus, a music and theatrical rights firm, in attempt to end months of infighting over the company's leadership and secure its future.

Read more
15 Apr 2024 09:26

IN BRIEF: Hipgnosis Songs Fund promotes Rampersaud to senior director

Hipgnosis Songs Fund Ltd - London-based music investment company - Promotes Non-Executive Director Cindy Rampersaud to senior independent director, effective from Friday last week. Rampersaud has been on the music royalty investor's board since August last year.

Read more
28 Mar 2024 11:26

Hipgnosis Songs Fund shares up after confirmation of portfolio value

(Alliance News) - Hipgnosis Songs Fund Ltd on Thursday confirmed the valuation of its portfolio was in line with an earlier estimate, giving its shares a boost.

Read more
18 Mar 2024 15:33

London close: Stocks slip ahead of central bank decisions

(Sharecast News) - London markets closed with a slight downturn on Monday as investors monitored upcoming rate decisions from a number of central banks.

Read more
18 Mar 2024 14:16

Hipgnosis Songs Fund reduces net assets after accounting mishap

(Alliance News) - Hipgnosis Songs Fund Ltd on Monday said it had identified an error in its latest operative net asset value calculation.

Read more
18 Mar 2024 09:30

SMALL-CAP WINNERS & LOSERS: abrdn Property Income takeover heats up

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Monday.

Read more
4 Mar 2024 15:29

London close: Stocks languish ahead of Wednesday's Budget

(Sharecast News) - London's stock markets finished in the red on Monday, reflecting investor apprehension ahead of the impending Spring Budget.

Read more
4 Mar 2024 11:52

LONDON MARKET MIDDAY: Stocks mostly lower ahead of UK Spring budget

(Alliance News) - Stock prices in London were mostly lower at midday Monday, as the week started off on a quiet note ahead of a busy week of monetary policy decisions and economic data from across the globe.

Read more
4 Mar 2024 10:50

Hipgnosis Songs Fund payout to stay on halt as portfolio value slashed

(Alliance News) - Hipgnosis Songs Fund Ltd on Monday said it will divert its free cashflow toward paying down debt and won't resume paying dividends "for the foreseeable future", as an independent study found a lower valuation for the company's portfolio.

Read more
4 Mar 2024 08:55

LONDON MARKET OPEN: Review cuts Hipgnosis Songs Fund valuation

(Alliance News) - Stock prices in London opened mostly lower on Monday, as investor attention remained primarily on the release of the UK Spring budget on Wednesday.

Read more
26 Feb 2024 09:03

Hipgnosis Songs Fund plans to bring High Court claim against founder

(Alliance News) - Hipgnosis Songs Fund Ltd on Monday said that it plans to bring a High Court claim against its founder, Merck Mercuriadis, after he refused to indemnify the company against liabilities.

Read more
19 Feb 2024 10:17

Hipgnosis Songs Fund taking founder to court over indemnity

(Alliance News) - Hipgnosis Songs Fund Ltd on Monday said that its request for an indemnity from its founder had been denied, prompting the company to pursue court action in pursuit of the full amount.

Read more
7 Feb 2024 14:09

IN BRIEF: Hipgnosis Songs votes in favour of fee to potential bidders

Hipgnosis Songs Fund Ltd - London-based investor in music rights - Says 99.9% of shareholders vote in favour of a special resolution at its extraordinary general meeting. This was to enshrine payment of a fee, at the board's discretion, of up to GBP20 million to any prospective bidders who approach the board seeking to make an acquisition of Hipgnosis assets on terms recommendable to shareholders. The fee is intended to protect bidders against due diligence and acquisition costs so that they are "not deterred from seeking to engage with company" over a possible offer. Chair Robert Naylor says: "The board remains focused on the strategic review, under which it is looking at all options to deliver shareholder value. The board will update shareholders as to the outcome of due diligence in due course."

Read more
6 Feb 2024 15:48

UK shareholder meetings calendar - next 7 days

Wednesday 7 February 
Asos PLCAGM
eEnergy Group PLCGM re disposal of Energy Management division
Future PLCAGM
Hipgnosis Songs Fund LtdEGM re payment of fee to prospective bidders
Mosman Oil & Gas LtdEGM re director participation in placing
Premier Miton Group PLCAGM
Thursday 8 February 
Benchmark Holdings PLCAGM
Compass Group PLCAGM
easyJet PLCAGM
Hargreave Hale AIM VCT PLCAGM
Polar Capital Global Healthcare Trust PLCAGM
Friday 9 February 
Kibo Energy PLCEGM re pre-emption rights for share issues
Victrex PLCAGM
Monday 12 February 
Arix Bioscience PLCGM re takeover by RTW Biotech Opportunities Ltd
JPMorgan UK Smaller Companies Investment Trust PLCGM re merger with JPMorgan UK Smaller Companies
Mears Group PLCGM re authority to buy back up to 10% of shares
Tuesday 13 February 
Cellular Goods PLCAGM
Iconic Labs PLCAGM
JPMorgan Indian Investment Trust PLCAGM
Tui AGAGM including London Stock Exchange delisting vote
Xtract Resources PLCGM re sale of Manica gold project to MMP
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.